OIE RL for «Lumpy Skin Disease» – «Tuppurainen » – «United Kingdom»
OIE Reference Laboratory Reports
Activities in 2012
Address of laboratory / The Pirbright Institute, Ash Road, Pirbright, Surrey, GU24 0NF, United Kingdom
Tel.: / +44 (0)1483 232441
Fax: / +44 (0)1483 232448
e-mail address: /
Name (including Title) of Head of Laboratory (Responsible Official): / Professor John Fazakerley
Name(including Title and Position) of OIE Reference Expert: / EevaTuppurainen, Vet Med Lic, MSc, MRCVS
Head of Capripoxvirus Reference Laboratory
Date of submission to the OIE / 20.01.2013
This form should be used by an OIE Reference Laboratory to report activities that took place from January through December of the past year (2012), unless otherwise stated, and must be submitted by the end of January every year.
Only those activities that concern the disease (or topic) for which the laboratory is recognised by the OIE should be mentioned. The questionnaire structure follows the Terms of Reference (ToRs) for OIE Reference Laboratories, available at:
EachToR(blueitalicised text)has been placed as a heading covering the group of questions related to it.
Please note the reditalicisedtext is given as guidance and should be deleted from your report and substitute with your data. Examples are based onpast Annual Reports or have been invented.
The questionnaire represents a means of gathering information on activities carried out by OIE Reference Laboratories and making it available to OIE Member Countries and to the OIE Reference Laboratory network.
This annual report will remain available for consultation on the OIE web site:
ToR:To use, promote and disseminate diagnostic methods validated according to OIE StandardsTest recommended by the OIE / Total number of test performed last year
Indirect diagnostic tests / Nationally / Internationally
Direct diagnostic tests / Nationally / Internationally
Virus isolation on bovine dermis or lambtestiscells/ 0 / 0
Real-time PCR/ 0 / 29
Serum neutralization test/ 0 / 9
ToR:To develop reference material in accordance with OIE requirements, and implement and promote the application of OIE Standards.
Tostore and distribute to national laboratories biological reference products and any other reagents used in the diagnosis and control of the designated pathogens or disease.
2.Did your laboratory produce or store imported standard reference reagentsofficially recognised by the OIE or other international bodies?
3.Did your laboratory supply standard reference reagentsto OIE Member Countries?
Yes (Reagents not certified by the OIE) NoType of reagent available / Related diagnostic test / Produced/
stored / Amount supplied nationally
(ml, mg) / Amount supplied internationally
(ml, mg) / Name of recipient OIE Member Countries and of institutions
Control positive sera / Neutralization tests / Produced / 0 / 2 ml / Nigeria, National Veterinary Research Institute
Control positive sera / Neutralization tests / Produced / 0 / 2 ml / Romania, Institute for Diagnosis and Animal Health
Control positive sera / Neutralization tests / Produced / 0 / 1 ml / Israel, Abic Biological Laboratories Ltd (Phibro)
LSDV Neethling strain / CapripoxPCR / Produced / 0 / 1 ml / Romania, Institute for Diagnosis and Animal Health
4.Did your laboratory produce diagnostic reagents other than the OIE-approved standard reference reagents?
5.Did your laboratory produce vaccines?
6.Did your laboratory supply vaccines to OIE Member Countries?
ToR:To develop, standardise and validate, according to OIE Standards, new procedures for diagnosis and control of the designated pathogens or diseases
7.Did your laboratory develop new diagnostic methods validated according to OIE Standards for the designated pathogen or disease?
8.Didyour laboratory develop new vaccines according to OIE Standards for the designated pathogen or disease?
Yes NoName of the new test or diagnostic method or vaccine developed / Description and References (Publication, website, etc.)
LAMP assay (preliminary validation carried out using capripox isolates and experimental samples available at ref lab stocks) / Murray et al. (2012). Detection of capripoxvirus DNA using a novel Loop-Mediated Isothermal Amplification assay, submitted, BMC Veterinary Research
ToR:To provide diagnostic testing facilities, and, where appropriate, scientific and technical advice on disease control measures to OIE Member Countries
9.Did your laboratory carry out diagnostic testing for other OIE Member Countries?
Yes NoName of OIE Member Country seeking assistance / Date
(dd/mm) / No. samples received for provision of diagnostic support (i.e. from surveillance campaign) / No. samples received for provision of confirmatory diagnoses
Uganda / 25 January / 32 / 0
Slovak Rebublic / 19 April / 6 / 0
10.Did your laboratory provide expert advice in technical consultancies on the request of an OIE Member Country?
Yes NoName of the OIE Member Country receiving a technical consultancy / Purpose / How the advice was provided
Kimron Veterinary Institute, Israel / Consultancy on recent LSD outbreak and LSDV seminar / In loco and remote assistance
Sultanate of Oman,Veterinary Research Center, Ministry of Agriculture and Fisheries / Consultancy on vaccines against LSDV / Remote assistance
Uganda, National Animal Disease Diagnostics and Epidemiology Centre / On-going twinning project / In loco and remote assistance
Jordan Bioindustries Centre (JOVAC), Jordan / Consultancy on diagnostic kits for capripoxviruses / Remote assistance
Food and Agriculture Organization of the United Nations (FAO) / Consultancy on lumpy skin disease / Remote assistance
Tanzania National Parks (Serengeti) / Consultancy on giraffe skin disease / Remote assistance
ToR:To carry out and/or coordinate scientific and technical studies in collaboration with other laboratories, centres or organisations
11.Did your laboratory participate in international scientific studies in collaboration with OIE Member Countries other than the own?
Yes NoTitle of the study / Duration / Purpose of the study / Partners (Institutions) / OIE Member Countries involved other than your country
Development and validation of novel diagnostic assays for capripoxviruses / On-going / To maximise the use of serum collections, virus isolates, field and experimental samples, of both laboratories / International Atomic Energy Agency (IAEA), Animal Production and Health Section, Austria
CapripoxvirusRL, The Pirbright Institute, UK / Austria / FAO
Determination of the role of hard (ixodid) ticks in the transmission of lumpy skin disease virus / On-going / Department of Veterinary Tropical Diseases, Faculty of Veterinary Science, University of Pretoria CapripoxvirusRL, The Pirbright Institute, UK / South Africa
Evaluation of the efficacy of three capripoxvirus live vaccine strains against lumpy skin disease virus in Ethiopia / On-going / National Animal Health Diagnostic and Investigation Center (NAHDIC), Ethiopia
National Veterinary Institute (NVI), Ethiopia
Centre for International Research for Agricultural Development (CIRAD), France
CapripoxvirusRL, The Pirbright Institute, UK / Ethiopia
ToR:To collect, process, analyse, publish and disseminate epizootiological data relevant to the designated pathogens or diseases
12.Didyour Laboratory collect epizootiologicaldata relevant to international disease control?
13.Didyour laboratory disseminate epizootiologicaldata that had been processed and analysed?
14.What method of dissemination of information is most often used by your laboratory?
(Indicate in the appropriate box the number by category)
a)Articles published in peer-reviewed journals:...... 6
b)International conferences:...... 4
c)National conferences:...... 1
List of publications:
Tuppurainen E.S.M. and Oura C.A.L. (2012). Review: Lumpy skin disease: an emerging threat to Europe, the Middle East and Asia. Transboundary and Emerging Diseases, 59 (1), 40-48. DOI: 10.1111/j.1865-1682.2011.01242.x
Stubbs S., Oura C.A.L., Henstock M., Bowden T.R., King D.P. and Tuppurainen E.S.M. (2012).Validation of a high-throughput real-time polymerase chain reaction assay for the detection of capripoxviral DNA.Journal of Virological Methods 179 (2), 419-422.
Magori-Cohen R., Louzoun Y., Hertziger Y., Oron E., Arazi A., Tuppurainen E., Shpigel N.Y. and Klement E. (2012) Mathematical modelling and evaluation of the different routes of transmission of lumpy skin disease virus. VeterinaryResearch, 43:1. DOI: 10.1186/1297-9716-43-1
Tuppurainen E.S.M., Lubinga J.C., Stoltsz W.H., Troskie M., Carpenter S.T., Coetzer J.A.W.,VenterE.H. and Oura C.A.L. (2012). Mechanical transmission of lumpy skin disease virus by Rhipicephalusappendiculatus male ticks.Epidemiology and Infection.doi: 10.1017/S0950268812000805
Tuppurainen E.S.M., Lubinga J.C., Stoltsz W.H., Troskie M., S.T. Carpenter, Coetzer J.A.W.,VenterE.H. and Oura C.A.L. (2012). Evidence of vertical transmission of lumpy skin disease virus in Rhipicephalus (Boophilus) decoloratus ticks, accepted, Ticks and Tick-borne Diseases –journal
Murray L., Edwards L., Tuppurainen E., Oura, C.A.L., Mioulet V., King D.P. (2012) Detection of capripoxvirus DNA using a novel Loop-Mediated Isothermal Amplification assay, submitted, BMC Veterinary Research
Lubinga JC, Tuppurainen ESM, Stoltsz WH, Coetzer JAW, VenterEH (2012) Detection of lumpy skin disease virus in saliva of Amblyommahebraeumand Rhipicephalusappendiculatus ticks post feeding on experimentally infected cattle” Faculty Day, Faculty of Veterinary Science, University of Pretoria, South Africa10.09.2012
Tuppurainen E.S.M. (2012) “Capripoxviruses - General overview” (2012). As a part of the OIE twinning project between Uganda NADDEC and IAH, a presentation was given at the Sample Management -training course for 120 Ugandan government field veterinarians, Entebbe, Uganda 3rd -6th Sept
Tuppurainen E.S.M., Lubinga J.C.,Stoltsz W.H., Troskie M., Carpenter S.T., Oura C.A.L., Coetzer J.A.W., VenterEH. (2012). “Transmission of lumpy skin disease virus by hard tick vectors”, a presentation was given at the Lumpy skin disease –seminar, Kimron Veterinary Institute, Israel, 20th Sept
Batten C., Ayebazibwe C., Oura C. and Tuppurainen E. (2012). “Twinning project focusing on several diseases – challenges and lessons learnt”. Regional Seminar on the OIE Laboratory Twinning Programme: Concepts and Perspectives, Johannesburg, South Africa, 9-10 Oct
Venter EH, Lubinga JC, Stoltsz WH, Troskie M, Oura C, Coetzer JAW, Tuppurainen E (2012). Mechanical and transstadial transmission of lumpy skin disease virus by Rhipicephalusappendiculatus and Amblyommahebraeum ticks. Poster to be presented at the IX International Congress of Veterinary Virology, 4 – 7 September, Madrid. Spain
ToR: To provide scientific and technical training for personnel from OIE Member Countries
To recommend the prescribed and alternative tests or vaccines as OIE Standards
15.Did your laboratory provide scientific and technical training to laboratory personnel from other OIE Member Countries?
a)Technical visits:...... 124
c)Hands-on training courses:...... 129
d)Internships (>1 month):...... 0Type of technical training provided (a, b,c or d) / Country of origin of the expert(s) provided with training / No. participants from the corresponding country
a, b, c / Uganda (training of laboratory personnel at NADDEC) / 4
b / Israel (Lumpy skin disease seminar at Kimron Veterinary Institute) / ~50
b / Uganda (Sample Management training course for field veterinarians) / 129
c / Spain, Romania, UAE and Uganda (Annual training course on capripoxvirus diagnostics at Pirbright) / 7
ToR:To maintain a system of quality assurance, biosafety and biosecurity relevant for the pathogen and the disease concerned
16.Does your laboratory have a Quality Management System certified according to an International Standard?
Yes NoQuality management system adopted
ISO 17025 (only for real-time PCR method)
17.Is your laboratory accredited by an international accreditation body?
Yes NoTest for which your laboratory is accredited / Accreditation body
Real-time PCR / UKAS
18.Does your laboratory maintain a “biorisk management system” for the pathogen and the disease concerned? (See Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 2012, Chapter 1.1.3 orManual of Diagnostic Tests for Aquatic Animals 2012, Chapter 1.1.1)
ToR:To organise and participate in scientific meetings on behalf of the OIE
19.Did your laboratory organise scientific meetings on behalf of the OIE?
20.Did your laboratory participate in scientific meetings on behalf of the OIE?
Yes NoTitle of event / Date
(mm/yy) / Location / Role (speaker, presenting poster, short communications) / Title of the work presented
OIE Regional Seminar on the OIE Laboratory Twinning Programme: Concepts and Perspectives / October/12 / Johannesburg, South Africa / speaker / Twinning project focusing on several diseases – challenges and lessons learnt
ToR:To establish and maintain a network with other OIE Reference Laboratories designated for the same pathogen or disease and organise regular inter-laboratory proficiency testing to ensure comparability of results
21.Did your laboratory exchange information with other OIE Reference Laboratories designated for the same pathogen or disease?
22.Was your laboratory involved in maintaining a network with OIE Reference Laboratories designated for the same pathogen or disease by organising or participating in proficiency tests?
Yes NoPurpose of the proficiency tests: (validation of a diagnostic protocol: specify the test; quality control of vaccines: specify the vaccine type, etc.) / Role of your Reference Laboratory (organiser/participant) / No. participants / Participating OIE Ref. Labs/ organising OIE Ref. Lab.
N/A during reporting period
23.Did your laboratory collaborate with other OIE Reference Laboratories for the same disease on scientific research projects for the diagnosis or control of the pathogen of interest?
ToR:To organise inter-laboratory proficiency testing with laboratories other than OIE Reference Laboratories for the same pathogens and diseases to ensure equivalence of results.
24.Did your laboratory organiseor participate in inter-laboratory proficiency tests with laboratories other than OIE Reference Laboratories for the same disease?
ToR:To place expert consultants at the disposal of the OIE
25.Did your laboratory place expert consultants at the disposal of the OIE?
Yes NoKind of consultancy / Location / Subject (facultative )
Provision of comments on OIE Standards / United Kingdom / The OIE Terrestrial Code Commission was provided with an expert advice/opinion on a number of comments from the European Union on the Terrestrial Code chapter on Lumpy skin disease that refers to the Terrestrial Manual chapter. A prescribed test for international trade of cattle for LSD was recommended
Annual reports of OIE Reference Laboratories, 20121